Cellebrite DI Analyst Price Targets - Benzinga

Cellebrite DI Ltd

CLBTNASDAQ

Trade with Public

Trade with Public

$11.45

-0.49-4.1%

At close: Sep 4, 5:00 PM EST

$11.55

0.100.87%

After Hours: Sep 4, 7:09 PM EST

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Cellebrite DI Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cellebrite DI (CLBT).

Price Target Range — 11 Quarters

Analyst Consensus — 9 Analysts

9Buy

Consensus RatingBuy# Analysts9Avg. Consensus PT$19Upside to Avg. PT+61.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Lake Street	Eric Martinuzzi	PT Cut	Buy	$21→$15
Aug 14, 2026	JP Morgan	Brian Essex	PT Cut	Overweight	$20→$16
Aug 14, 2026	DA Davidson	Rudy Kessinger	PT Cut	Buy	$22→$15
Aug 14, 2026	Needham	Mike Cikos	PT Cut	Buy	$15→$13
Aug 6, 2026	DA Davidson	Rudy Kessinger	PT Raise	Buy	$20→$22
May 27, 2026	DA Davidson	Rudy Kessinger	Initiate	Buy	$20
May 15, 2026	Needham	Mike Cikos	PT Cut	Buy	$18→$15
Feb 12, 2026	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Nov 13, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$23→$24
Nov 13, 2025	Lake Street	Eric Martinuzzi	PT Raise	Buy	$22→$23
Nov 13, 2025	B of A Securities	Tal Liani	PT Raise	Buy	$24→$25
Nov 13, 2025	Needham	Mike Cikos	PT Raise	Buy	$22→$24
Sep 24, 2025	JP Morgan	Brian Essex	PT Raise	Overweight	$20→$23
Aug 15, 2025	Lake Street	Eric Martinuzzi	PT Cut	Buy	$24→$22
Aug 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$24→$18
Jun 23, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$22→$20
Jun 6, 2025	Needham	Mike Cikos	Maintained	Buy	$24
May 15, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$25→$22
May 14, 2025	Needham	Mike Cikos	PT Cut	Buy	$28→$24
May 12, 2025	JP Morgan	Brian Essex	PT Cut	Overweight	$29→$25

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Lake Street Maintains Buy on Cellebrite DI, Lowers Price Target to $15

Lake Street analyst Eric Martinuzzi maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $21 to $15.

Benzinga Newsdesk

PRO
JP Morgan Maintains Overweight on Cellebrite DI, Lowers Price Target to $16

JP Morgan analyst Brian Essex maintains Cellebrite DI (NASDAQ:CLBT) with a Overweight and lowers the price target from $20 to $16.

Benzinga Newsdesk

PRO
DA Davidson Maintains Buy on Cellebrite DI, Lowers Price Target to $15

DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $22 to $15.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $12.5

Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $15 to $12.5.

Benzinga Newsdesk

PRO
DA Davidson Maintains Buy on Cellebrite DI, Raises Price Target to $22

DA Davidson analyst Rudy Kessinger maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and raises the price target from $20 to $22.

Benzinga Newsdesk

PRO
DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20

DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.

Benzinga Newsdesk